Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Walden Biosciences

Clinical trials sponsored by Walden Biosciences, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to slow kidney damage in diabetes and rare diseases Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug aims to slow kidney damage in diabetes and rare diseases

Disease control Recruiting now

This study tests an experimental drug called WAL0921 in 96 adults with kidney diseases that cause protein in the urine, including diabetic nephropathy and several rare conditions. Participants receive either the drug or a placebo as an IV infusion every two weeks for 14 weeks, th…

Phase 2 • Sponsor: Walden Biosciences • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC